Endocrine persistence in ER+ breast cancer is accompanied by metabolic vulnerability in oxidative phosphorylationSteven Tau, Todd W. Miller|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 3
Endocrine therapy induces oxidative stress in ER+ breast cancer that sensitizes persister cells to ferroptosisSteven Tau, Todd W. Miller|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 0